Ambrose Kristen 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Feb 19, 2025
Insider Transaction Report
Form 4
Ambrose Kristen
SVP & Chief Accounting Officer
Transactions
- Tax Payment
Common Stock
2025-02-14$463.46/sh−564$261,391→ 11,469 total - Sale
Common Stock
2025-02-18$455.06/sh−671$305,345→ 10,798 total
Footnotes (1)
- [F1]Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1, which was entered into on 08/08/2024.